Association of Childhood Psychosocial Environment With 30-Year Cardiovascular Disease Incidence and Mortality in Middle Age.
Adolescent
Adult
Adverse Childhood Experiences
Age Factors
Cardiovascular Diseases
/ diagnosis
Environment
Female
Heart Disease Risk Factors
Humans
Incidence
Longitudinal Studies
Male
Risk Assessment
Social Determinants of Health
Socioeconomic Factors
Stress, Psychological
/ epidemiology
Time Factors
United States
/ epidemiology
Young Adult
adverse childhood experiences
cardiovascular events
lifetime risk
longitudinal cohort study
mortality
stress
Journal
Journal of the American Heart Association
ISSN: 2047-9980
Titre abrégé: J Am Heart Assoc
Pays: England
ID NLM: 101580524
Informations de publication
Date de publication:
05 05 2020
05 05 2020
Historique:
pubmed:
29
4
2020
medline:
11
3
2021
entrez:
29
4
2020
Statut:
ppublish
Résumé
Background Childhood adversity and trauma have been shown to be associated with poorer cardiovascular disease (CVD) outcomes in adulthood. However, longitudinal studies of this association are rare. Methods and Results Our study used the CARDIA (Coronary Artery Risk Development in Young Adults) Study, a longitudinal cohort that has followed participants from recruitment in 1985-1986 through 2018, to determine how childhood psychosocial environment relates to CVD incidence and all-cause mortality in middle age. Participants (n=3646) completed the Childhood Family Environment (CFE) questionnaire at the year 15 (2000-2001) CARDIA examination and were grouped by high, moderate, or low relative CFE adversity scores. We used sequential multivariable regression models to estimate hazard ratios of incident (CVD) and all-cause mortality. Participants were 25.1±3.6 years old, 47% black, and 56% female at baseline and 198 participants developed CVD (17.9 per 10 000 person-years) during follow-up. CVD incidence was >50% higher for those in the high CFE adversity group compared with those in the low CFE adversity group. In fully adjusted models, CVD hazard ratios (95% CI) for participants who reported high and moderate CFE adversity versus those reporting low CFE adversity were 1.40 (0.98-2.11) and 1.25 (0.89-1.75), respectively. The adjusted hazard ratios for all-cause mortality was 1.68 (1.17-2.41) for those with high CFE adversity scores and 1.55 (1.11-2.17) for those with moderate CFE adversity scores. Conclusions Adverse CFE was associated with CVD incidence and all-cause mortality later in life, even after controlling for CVD risk factors in young adulthood.
Identifiants
pubmed: 32342717
doi: 10.1161/JAHA.119.015326
pmc: PMC7428574
doi:
Types de publication
Journal Article
Multicenter Study
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
e015326Subventions
Organisme : NHLBI NIH HHS
ID : HHSN268201800005I
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201800007I
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201800003I
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201800006I
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201800004I
Pays : United States
Commentaires et corrections
Type : CommentIn
Type : CommentIn
Références
Stat Med. 1985 Oct-Dec;4(4):543-7
pubmed: 4089356
Psychoneuroendocrinology. 2012 Jul;37(7):1009-18
pubmed: 22178583
Curr Cardiol Rep. 2015 Oct;17(10):88
pubmed: 26289252
J Neurosci. 2008 Jan 23;28(4):990-9
pubmed: 18216206
Lancet. 2017 Feb 25;389(10071):834-845
pubmed: 28088338
Child Abuse Negl. 2016 Jun;56:1-10
pubmed: 27107504
Psychoneuroendocrinology. 2010 Jul;35(6):932-43
pubmed: 20116177
Circulation. 2010 Feb 2;121(4):586-613
pubmed: 20089546
Circulation. 2015 May 12;131(19):1674-81
pubmed: 25858196
Psychosom Med. 2014 Jun;76(5):327-36
pubmed: 24933013
Soc Sci Med. 2014 Mar;104:15-22
pubmed: 24581057
Stat Med. 2011 Feb 20;30(4):377-99
pubmed: 21225900
N Engl J Med. 1997 Apr 3;336(14):973-9
pubmed: 9077376
JAMA. 1999 Nov 3;282(17):1652-8
pubmed: 10553792
Mayo Clin Proc. 2017 Sep;92(9):1415-1421
pubmed: 28870356
Am J Epidemiol. 1977 Sep;106(3):203-14
pubmed: 900119
Acta Psychiatr Scand. 2014 Mar;129(3):180-92
pubmed: 24205846
Psychosom Med. 2006 Jan-Feb;68(1):41-50
pubmed: 16449410
Int J Equity Health. 2017 Sep 7;16(1):170
pubmed: 28882142
Circulation. 2004 Sep 28;110(13):1761-6
pubmed: 15381652
JAMA Psychiatry. 2019 Jun 1;76(6):584-593
pubmed: 30892562
Thromb Res. 2010 Nov;126(5):386-92
pubmed: 20800268
Soc Sci Med. 2009 Mar;68(5):791-8
pubmed: 19185965
Dev Psychopathol. 2012 Nov;24(4):1417-25
pubmed: 23062307
Heart. 2010 Feb;96(4):298-303
pubmed: 20194205
Clin Psychol (New York). 2017 Jun;24(2):125-139
pubmed: 28867878
Biol Psychiatry. 2006 Oct 15;60(8):819-24
pubmed: 16712805
J Am Heart Assoc. 2020 May 5;9(9):e015326
pubmed: 32342717
Brain Behav Immun. 2012 Feb;26(2):239-50
pubmed: 22138616
Metabolism. 2015 Nov;64(11):1408-18
pubmed: 26404480
J Public Health (Oxf). 2014 Mar;36(1):81-91
pubmed: 23587573
Proc Natl Acad Sci U S A. 2007 Jan 23;104(4):1319-24
pubmed: 17229839
JAMA Pediatr. 2018 Nov 1;172(11):1038-1044
pubmed: 30242348
Mol Psychiatry. 2016 May;21(5):642-9
pubmed: 26033244
Psychosom Med. 2011 Sep;73(7):563-71
pubmed: 21810898
Dev Psychol. 2015 Nov;51(11):1630-44
pubmed: 26389605
Health Psychol. 2009 May;28(3):338-46
pubmed: 19450040
Am J Prev Med. 1998 May;14(4):245-58
pubmed: 9635069
Circulation. 2018 Jan 30;137(5):e15-e28
pubmed: 29254928
JAMA. 2009 Jun 3;301(21):2252-9
pubmed: 19491187
J Adolesc Health. 2007 Jul;41(1):3-13
pubmed: 17577528
N Engl J Med. 2000 Mar 23;342(12):836-43
pubmed: 10733371
J Child Psychol Psychiatry. 2004 Feb;45(2):260-73
pubmed: 14982240
Psychosom Med. 2005 Nov-Dec;67(6):846-54
pubmed: 16314588
Prog Neuropsychopharmacol Biol Psychiatry. 2009 Aug 1;33(5):889-94
pubmed: 19389455
J Clin Epidemiol. 1988;41(11):1105-16
pubmed: 3204420